The Impact of Treatment Expectations on Exposure Process and Treatment Outcome in Childhood Anxiety Disorders.
Longitudinal Study of Sleep and Internalizing Problems in Youth Treated for Pediatric Anxiety Disorders.
The Effects of Youth Anxiety Treatment on School Impairment: Differential Outcomes Across CBT, Sertraline, and their Combination.
Multi-informant Expectancies and Treatment Outcomes for Anxiety in Youth.
Acceptability, feasibility, and efficacy of Internet cognitive behavioral therapy (iCBT) for pediatric obsessive-compulsive disorder: a systematic review.
Distinct trajectories of long-term symptom severity in pediatric obsessive-compulsive disorder during and after stepped-care treatment.
Incident Substance Use Disorder Following Anxiety Disorder in Privately Insured Youth.
Mood and suicidality outcomes 3-11 years following pediatric anxiety disorder treatment.
Symptom-specific effects of cognitive-behavioral therapy, sertraline, and their combination in a large randomized controlled trial of pediatric anxiety disorders.
The Emotional and Behavioral Impact of Delivering Bad News to Virtual versus Real Standardized Patients: A Pilot Study.
Sensory Over-Responsivity: An Early Risk Factor for Anxiety and Behavioral Challenges in Young Children.
Person-Centered Profiles Among Treatment-Seeking Children and Adolescents with Anxiety Disorders.
Psychotherapy Claims Surrounding Pharmacotherapy Initiation in Children and Adolescents with Anxiety Disorders.
Incidence of mental health hospitalizations, treated self-harm, and emergency room visits following new anxiety disorder diagnoses in privately insured U.S. children.
Child and Adolescent Adherence With Cognitive Behavioral Therapy for Anxiety: Predictors and Associations With Outcomes.
Acceptance-enhanced behavior therapy for trichotillomania: Randomized controlled trial rationale, method, and strategies for recruiting minority participants.
Electrophysiological Biomarkers Predict Clinical Improvement in an Open-Label Trial Assessing Efficacy of Autologous Umbilical Cord Blood for Treatment of Autism.
Correction to: Social Interpretation Bias in Children and Adolescents with Anxiety Disorders: Psychometric Examination of the Self-report of Ambiguous Social Situations for Youth (SASSY) Scale (Child & Youth Care Forum, (2017), 46, 3, (395-412), 10.1007/s10566-016-9381-y)Read Full Text
Cognitive-behavioral therapy for youth anxiety: An effectiveness evaluation in community practice.
Results from the Child/Adolescent Anxiety Multimodal Longitudinal Study (CAMELS): Functional outcomes.
Results From the Child/Adolescent Anxiety Multimodal Extended Long-Term Study (CAMELS): Primary Anxiety Outcomes.
Examining Parental Medication Adherence as a Predictor of Child Medication Adherence in Pediatric Anxiety Disorders.
Defining Treatment Response and Remission in Youth Anxiety: A Signal Detection Analysis With the Multidimensional Anxiety Scale for Children.
Children's and Parents' Ability to Tolerate Child Distress: Impact on Cognitive Behavioral Therapy for Pediatric Obsessive Compulsive Disorder.
Mediators of Treatment Outcomes for Anxious Children and Adolescents: The Role of Somatic Symptoms.
The Interplay of Familial and Individual Risk in Predicting Clinical Improvements in Pediatric Anxiety Disorders.
Therapist-Reported Features of Exposure Tasks That Predict Differential Treatment Outcomes for Youth With Anxiety.
One-Year Outcome for Responders of Cognitive-Behavioral Therapy for Pediatric Obsessive-Compulsive Disorder.
Developing Adaptive Treatment Strategies to Address Suicidal Risk in College Students: A Pilot Sequential, Multiple Assignment, Randomized Trial (SMART).
Sleep-Related Problems and the Effects of Anxiety Treatment in Children and Adolescents.
Developmental Differences in Functioning in Youth With Social Phobia.
Placebo Response in Pediatric Anxiety Disorders: Results from the Child/Adolescent Anxiety Multimodal Study.
Social Interpretation Bias in Children and Adolescents with Anxiety Disorders: Psychometric Examination of the Self-report of Ambiguous Social Situations for Youth (SASSY) Scale.
Clarifying the Relationship between Trichotillomania and Anxiety.
Extended Release Guanfacine in Pediatric Anxiety Disorders: A Pilot, Randomized, Placebo-Controlled Trial.
Trauma and trichotillomania: A tenuous relationshipRead Full Text
Factor analysis of the Milwaukee Inventory for Subtypes of Trichotillomania-Adult Version.
Photographic Assessment of Change in Trichotillomania: Psychometric Properties and Variables Influencing InterpretationRead Full Text
Comorbidity and quality of life in adults with hair pulling disorder.
Mediators of change in the Child/Adolescent Anxiety Multimodal Treatment Study.
DSM-5 Trichotillomania: Perception of Adults With Trichotillomania After Psychosocial Treatment.
Defining treatment response in trichotillomania: a signal detection analysis.
Anxiety Disorders in Caucasian and African American Children: A Comparison of Clinical Characteristics, Treatment Process Variables, and Treatment Outcomes.
Initial Prescription Medication for Children with Anxiety: Concordance with EvidenceRead Full Text
Examining DSM criteria for trichotillomania in a dimensional framework: implications for DSM-5 and diagnostic practice.
Academic Impairment and Impact of Treatments Among Youth with Anxiety DisordersRead Full Text
Continued cognitive-behavior therapy versus sertraline for children and adolescents with obsessive-compulsive disorder that were non-responders to cognitive-behavior therapy: Treatment outcome and moderator analysisRead Full Text
Tics Moderate Sertraline, but Not Cognitive-Behavior Therapy Response in Pediatric Obsessive-Compulsive Disorder Patients Who Do Not Respond to Cognitive-Behavior Therapy.
Continued cognitive-behavior therapy versus sertraline for children and adolescents with obsessive-compulsive disorder that were non-responders to cognitive-behavior therapy: a randomized controlled trial.
Trajectories of change in youth anxiety during cognitive-behavior therapy.
Predicting Anxiety Diagnoses and Severity with the CBCL-A: Improvement Relative to Other CBCL Scales?
Child/Adolescent anxiety multimodal study: evaluating safety.
Predictors associated with improved cognitive-behavioral therapy outcome in pediatric obsessive-compulsive disorder.
Parental anxiety as a predictor of medication and CBT response for anxious youth.
Anxiety in youth with and without autism spectrum disorder: examination of factorial equivalence.
Measuring the role of psychological inflexibility in Trichotillomania.
Advances in data analytic methods for evaluating treatment outcome and mechanisms of change: introduction to the special issue.
Somatic complaints in anxious youth.
Fear and anxiety from principle to practice: implications for when to treat youth with anxiety disorders.
Family-based treatment of early childhood obsessive-compulsive disorder: the Pediatric Obsessive-Compulsive Disorder Treatment Study for Young Children (POTS Jr)--a randomized clinical trial.
Predictors and moderators of treatment response in childhood anxiety disorders: results from the CAMS trial.
Naturalistic follow-up of youths treated for pediatric anxiety disorders.
24- and 36-week outcomes for the Child/Adolescent Anxiety Multimodal Study (CAMS).
A probabilistic and individualized approach for predicting treatment gains: an extension and application to anxiety disordered youth.
Assessing anxiety in youth with the multidimensional anxiety scale for children.
The therapeutic relationship in cognitive-behavioral therapy and pharmacotherapy for anxious youth.
Therapist Factors and Outcomes in CBT for Anxiety in Youth.
The impact of Tourette Syndrome in adults: results from the Tourette Syndrome impact survey.
Defining treatment response and remission in child anxiety: signal detection analysis using the pediatric anxiety rating scale.
Effect of a paraprofessional home-visiting intervention on American Indian teen mothers’ and infants’ behavioral risks: a randomized controlled trial.
SMARTer discontinuation trial designs for developing an adaptive treatment strategy.
Designing a pilot sequential multiple assignment randomized trial for developing an adaptive treatment strategy.
A phenomenological investigation of women with Tourette or other chronic tic disorders.
Remission after acute treatment in children and adolescents with anxiety disorders: findings from the CAMS.
Cognitive behavior therapy augmentation of pharmacotherapy in pediatric obsessive-compulsive disorder: the Pediatric OCD Treatment Study II (POTS II) randomized controlled trial.
Exploring the impact of chronic tic disorders on youth: results from the Tourette Syndrome Impact Survey.
The roles of anxiety and depression in connecting tic severity and functional impairment.
Habit Reversal Training and Acceptance and Commitment Therapy for Tourette Syndrome: A Pilot ProjectRead Full Text
Clinical characteristics of anxiety disordered youth.
Review: Pharmacotherapy increases response and reduces symptom severity in paediatric anxiety disordersRead Full Text
Use of Antidepressants in Children: Is It Time for a Comparative Effectiveness Trial? Deputy Editor's CommentRead Full Text
Child/Adolescent Anxiety Multimodal Study (CAMS): rationale, design, and methods.
Statistics and research methodology at ABCT: AMASS and beyondRead Full Text
Depressive symptoms and clinical status during the Treatment of Adolescent Suicide Attempters (TASA) Study.
The Treatment of Adolescent Suicide Attempters study (TASA): predictors of suicidal events in an open treatment trial.
The authors replyRead Full Text
Behavioral Therapy, Sertraline, or Both in Childhood Anxiety ReplyRead Full Text
The child and adolescent psychiatry trials network (CAPTN): infrastructure development and lessons learned.
An Annotated Bibliography of Evidence for Diagnostic-Specific Psychosocial and Psychopharmacological InterventionsRead Full Text
Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety.
Attention bias toward threat in pediatric anxiety disorders.
Early childhood OCD: preliminary findings from a family-based cognitive-behavioral approach.
Pharmacotherapy for anxiety disorders in children and adolescents: an evidence-based medicine review.
Pharmacotherapy for anxiety disorders in children and adolescents: An evidence-based medicine reviewRead Full Text
What is the question? A comment on "investigating treatment mediators when simple random assignment to a control group is not possible"Read Full Text
Assessment of childhood depressionRead Full Text
Principles of cognitive-behavioral therapy for anxiety disorders in childrenRead Full Text
CBT VERSUS SUPPORTIVE THERAPY FOR DEPRESSIONRead Full Text
The case for practical clinical trials in psychiatry.
Cognitive-behavioral psychotherapy for anxiety and depressive disorders in children and adolescents: an evidence-based medicine review.
The Child and Adolescent Psychiatry Trials Network (CAPTN).
Effect of poverty on emotional symptoms in children.
Effect of poverty on emotional symptoms in children - ReplyRead Full Text
Relationships between poverty and psychopathology: a natural experiment.
Involuntary outpatient commitment and homelessness in persons with severe mental illness.
Searching for Moderators and Mediators of Pharmacological Treatment Effects in Children and Adolescents With Anxiety DisordersRead Full Text
Case-mix adjustment of adolescent mental health treatment outcomes.
Review of the evidence base for treatment of childhood psychopathology: internalizing disorders.
Review of the evidence base for treatment of childhood psychopathology: externalizing disorders.
The Pediatric Anxiety Rating Scale (PARS): development and psychometric properties.
Sertraline in children and adolescents with social anxiety disorder: an open trial.
Fluvoxamine for the treatment of anxiety disorders in children and adolescents. The Research Unit on Pediatric Psychopharmacology Anxiety Study Group.
Datapoints: Effects of changing from five to ten preauthorized outpatient sessions.
Social phobia and separation anxiety symptoms in community and clinical samples of children and adolescents.
Treating Pediatric Anxiety: Initial Use of SSRIs and Other Antianxiety Prescription Medications.